← The Wire
PTHSNYSE
Pelthos Therapeutics Inc.
Biological Products, (No Diagnostic Substances) · NV · CIK 1919246
Pelthos Therapeutics commercializes innovative therapeutic products, including FDA-approved ZELSUVMI, XEPI, and XEGLYZE
red 8-K · 90d
$96M
Market cap
$27.55
Last close
-5.1%
1D
-5.9%
5D
27K
Volume
Price · last 39 sessions+11.0%
May 4L $24.82 · H $29.50Jun 29
67
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureMay 28, 20268-KAuditor Change · Executive ChangeMay 21, 20268-KResults of Operations · Reg FD DisclosureMay 14, 202610-Q10-QMay 14, 20268-KReg FD DisclosureApr 14, 20268-KExecutive Change · Reg FD DisclosureApr 10, 20268-KResults of Operations · Reg FD DisclosureMar 19, 202610-K10-KMar 19, 20268-KMaterial Agreement · New Debt / ObligationJan 13, 20268-KExecutive Change · Reg FD DisclosureJan 12, 20268-KMaterial Agreement · Company UpdateJan 2, 20268-KExecutive Change · Company UpdateDec 23, 20258-KShareholder VoteDec 17, 2025DEF 14ADEF 14ANov 25, 20258-KResults of Operations · Reg FD DisclosureNov 13, 202510-Q10-QNov 13, 20258-KMaterial Agreement · New Debt / ObligationNov 7, 20258-KReg FD DisclosureOct 14, 20258-K/AAcquisition / Disposition · Results of OperationsSep 16, 20258-KReg FD DisclosureSep 3, 20258-KResults of Operations · Reg FD DisclosureAug 18, 202510-Q10-QAug 13, 20258-KChange of Control · Executive ChangeJul 2, 202510-Q10-QMay 13, 20258-KReg FD DisclosureMay 1, 20258-KAuditor Change · Material AgreementApr 17, 202510-K10-KMar 27, 20258-KMaterial Agreement · New Debt / ObligationMar 3, 20258-KReg FD DisclosureNov 21, 20248-KExecutive Change · Material AgreementNov 18, 202410-Q10-QNov 13, 20248-KShareholder Vote · Company UpdateOct 24, 2024DEF 14ADEF 14ASep 26, 202410-Q10-QAug 13, 20248-KCompany UpdateAug 7, 2024S-1S-1Jul 29, 20248-KMaterial Agreement · New Debt / ObligationJul 29, 202410-Q10-QMay 15, 202410-K10-KApr 16, 20248-KCompany UpdateApr 9, 20248-KReg FD DisclosureMar 21, 20248-KExecutive Change · Company UpdateMar 18, 20248-KReg FD DisclosureMar 13, 2024SC 13GSC 13GMar 4, 2024SC 13GSC 13GMar 1, 2024SC 13GSC 13GMar 1, 2024SC 13GSC 13GMar 1, 2024SC 13GSC 13GMar 1, 2024SC 13GSC 13GMar 1, 2024SC 13DSC 13DFeb 26, 20248-KMaterial Agreement · Equity IssuanceFeb 22, 2024424B4424B4Feb 20, 2024424B4424B4Feb 20, 2024S-1/AS-1/AFeb 14, 2024S-1/AS-1/AFeb 12, 2024S-1/AS-1/AFeb 7, 2024S-1/AS-1/AJan 30, 2024S-1/AS-1/AJan 16, 2024S-1/AS-1/ANov 8, 2023S-1/AS-1/AOct 25, 2023S-1/AS-1/AOct 16, 2023S-1/AFORM S-1 AMENDMENTSep 1, 2023S-1/AS-1/AJul 20, 2023S-1/AS-1/AJun 30, 2023S-1/AS-1/AMay 1, 2023S-1/AS-1/AJan 20, 2023S-1S-1Jan 11, 2023
Insider Activity
In the 90 days to Nov 25, 2025: 1 sold $280K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 5,999 | $28.00 | $168K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 2,000 | $28.14 | $56K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 2,000 | $28.01 | $56K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 1 | $28.50 | $29 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance